News for BioStem Technologies, Inc. (BSEM)

**media[644202]**

BioStem Technologies (OTC: BSEM) to participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami. CEO Jason Matuszewski will engag

**media[639009]**

**media[633996]**

BioStem Technologies, Inc. (OTCPK:BSEM) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ETCompany ParticipantsAdam Holdsworth - Director-Investor...

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. ( BSEM), a leading Me

BioStem Technologies (OTC: BSEM) to present at Centri Capital Conference on April 22, 2025. CEO Jason Matuszewski to highlight the proprietary BioREtain

**media[600306]**

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024Achieves prelimina

BioStem Technologies (BSEM) reported a record fourth-quarter 2024 net revenue of $102.9 million, showing a 791% year-over-year increase. The company's f

**media[548307]**

Study comparing BioStem's proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinic

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

POMPANO BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. ( BSEM) (”œBioStem”, ”œwe”, ”œus”, or ”œour”), a leading MedTech

**media[504090]**

Presentation to be webcast at 2:30 PM PT on Monday, January 13, 2025 POMPANO BEACH, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. ( BSE

Company Records First Commercial Sale of revyveâ„¢ Wound GelWINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)

Company Records First Commercial Sale of revyveâ„¢ Wound Gel WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; KNBIF) (”

**media[478650]**